Articles tagged with Translational Research
The IADR/AADR have released the first issue of JDR Clinical & Translational Research, a journal focusing on the translation of research into clinical practice. The inaugural issue covers various topics in applied oral health research, with an emphasis on rapid dissemination and application.
SAGE's new publication, JDR Clinical & Translational Research, expands on the success of Journal of Dental Research supplements. The journal accepts various study designs and methodologies, aiming to translate research findings into practical applications for oral health.
Rettsyndrome.org announces new Translational Research Awards to tackle nonsense mutations in MECP2 gene, aiming to develop treatments for Rett syndrome. The awards include the Read-Through Program and Neuro-Habilitation grants, furthering research towards new pharmacologic treatments and improved clinical practices.
A special issue of Biopreservation and Biobanking Journal explores China's biobanking strategy, highlighting its role in accelerating translational research. The articles discuss the country's biosample collection, analysis capabilities, and ethical management guidelines.
Vanderbilt University researchers found that chlorhexidine cloths did not reduce health care-associated infections in critically ill patients compared to non-antimicrobial cloths. The study analyzed data from over 9,300 ICU patients and showed no significant difference in infection rates between the two groups.
Columbia University has been awarded a $31 million NIH grant to create the Center for Excellence for Translational Research at Columbia's CII. The center will bring together researchers from diverse fields to develop insights into disease mechanisms and methods for detecting infectious agents.
The Block ICTR provides a comprehensive framework for translating biomedical discoveries into new treatments, with resources for community engagement, biostatistics, and clinical trials. Einstein and Montefiore will leverage their unique strengths to support innovative research programs across multiple disease areas.
The University of Utah Center for Clinical and Translational Science has received a $20.4 million grant from the NIH to advance translational research in medicine, particularly in rare conditions such as spinal muscular atrophy. The center will utilize this funding to support all aspects of translational research over the next five years.
The estate of Charles Meixner has donated $3 million to Autism Speaks, supporting translational postdoctoral fellowships and research into autism spectrum disorder. The gift will contribute to the development of new treatments and improve the lives of individuals and families affected by ASD.
A special issue of Translational Research highlights the progress and challenges of gene therapy research, focusing on clinically meaningful studies that combine patient observations with smart experiments. The approach of gene therapy may be applicable to all genetic disorders, offering a promising path for treatment and cure.
The ICTS will focus on translating genetic and genomic research into patient care, developing new therapeutics, and disseminating research findings. The grant supports Washington University's strengths in genetic and genomic research and its efforts to advance clinical and translational research.
The University of Missouri's Coulter Translational Partnership Program has awarded funding to five teams of physicians and engineers to improve healthcare. The program aims to turn laboratory discoveries into new products and services for patients, leveraging MU's substantial resources for biomedical innovation.
Researchers at the University of Utah will investigate the molecular causes of blood clots, which threaten millions of people worldwide. The center aims to apply basic science to find new diagnostic and therapeutic measures for thrombosis, making them available to patients rapidly.
The University of Michigan will use the funding to train researchers, provide tools and services, and involve more volunteers in their work. Over 11,000 people have already signed up for the registry.
Researchers found that small arteries showed signs of artery damage and reduced compliance after just six weeks on a high-fat diet, while large arteries remained unaffected. This early stage of damage may be the first step in developing high blood pressure.
The UNC Center for Diabetes Translation Research to Reduce Health Disparities aims to reduce diabetes-related disparities among poor and underserved populations. The center will leverage existing resources at NC TraCS Institute and partner with several universities and health departments to foster translational research.
The National Institutes of Health has awarded $200 million over five years to five health research centers to speed scientific discoveries into treatments for patients. The grants support the innovation and partnerships necessary to bridge basic research and medical practice.
The UK's NIHR Biomedical Research Centres have established a cutting-edge translational research infrastructure, driving progress in disease research and treatment. With strong focus on interdisciplinary working, public engagement, and industry partnerships, the centres aim to deliver rapid benefits for patients.
Dr. Thomas J. Walsh, Director of the Transplantation-Oncology Infectious Diseases Program at Weill Cornell Medical College, has been selected as the 2010 laureate of the sanofi-aventis ICAAC Award for his groundbreaking work on antifungal pharmacology and therapeutics.
The Prostate Cancer Translational Research in Europe meeting showcased ongoing research efforts to identify biomarkers, genetic variants and new therapeutic options. Researchers discussed the importance of collaboration between clinicians and scientists to streamline current efforts and avoid duplication.
The University of Cincinnati has been awarded nearly $23 million by the National Institutes of Health to support clinical and translational science research. The funding will be used to enhance research capabilities, increase community engagement, and facilitate interdisciplinary collaboration.
A new set of tools, 'Pathways to Clinical Goals,' aims to improve the translational research process, accelerating cancer therapy approval. The six pathways address various categories, including anti-cancer agents and lifestyle alterations, to clarify and streamline the research process.
The Boston University Clinical and Translational Science Institute will integrate research across departments and schools, facilitating interactions and incorporating community-based needs. The award aims to improve treatment efficiency and access to patient care.
The National Institutes of Health has awarded a $25 million Clinical and Translational Science Award to Indiana University School of Medicine. The grant will fund translational research activities at IU and Purdue universities, combining strengths in medicine, business, and government.
The International Diabetes Federation has supported a diabetes awareness and prevention project in Jordan, aiming to reverse the growing epidemic. The project aims to provide health education opportunities and practical experience through workshops and social support groups.
The IDF BRIDGES translational research grant program will fund a pilot study in the Philippines that aims to improve diabetes care in rural communities using local health workers. The program, called Diabetes Self-Management Program (DSME), will provide culturally-appropriate education and self-care practices for Filipinos with diabetes.
The Burroughs Wellcome Fund has awarded $9.75 million to 13 translational researchers through its Clinical Scientist Awards in Translational Research. These awards support established physician-scientists exploring scientific questions, applying knowledge at the bedside, and bringing insights back to the laboratory.
Jeffrey A. Toretsky, a pediatric oncology physician and researcher at Georgetown University's Lombardi Comprehensive Cancer Center, has received a prestigious Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund. The award will support his research to identify molecular mechanisms of EWS-FLI1 and develop ...
The University of Wisconsin-Madison's Institute for Clinical and Translational Research (ICTR) has received a $41 million NIH grant to build a network of partners across campus and around the state. This initiative aims to accelerate biomedical discoveries into practical healthcare applications, with a focus on community-based research...
The National Institutes of Health has awarded the University of Chicago Medical Center nearly $23 million to conduct translational research. This project aims to develop personalized therapies and improve access to medical care for the diverse population of the South Side of Chicago, where health disparities are prevalent.
The Johns Hopkins Institute for Clinical and Translational Research (ICTR) aims to speed up the translation of promising research from labs to clinics and eventually to communities. The ICTR will support over 100 faculty members across various schools, enabling them to form relationships with outside organizations and partner with heal...
The NCRR has launched a Translational Research Network to facilitate multi-site clinical and translational research among minority institutions. The network will enable researchers to pool resources and expertise, increasing the productivity and impact of individual centers.
The Burroughs Wellcome Fund has awarded a total of $8.25 million to support established physician-scientists conducting translational research. This funding will enable these researchers to explore scientific questions, apply their knowledge at the bedside, and bring insights back to the laboratory.
A new NIH-funded program co-directed by the Mailman School faculty will expedite clinical research, transforming how medical discovery is made. The center will centralize core resources for clinical researchers and enhance collaboration among scientific communities.
The NIH will provide $54 million over five years to Columbia University Medical Center to establish an Irving Institute for Clinical and Translational Research. This investment will enable the expansion of core resources available to clinical researchers, including biomedical informatics support and biostatistical analysis.
The University of Pittsburgh is awarded a $83.5 million NIH grant to establish the Clinical and Translational Science Institute (CTSI), aiming to transform clinical research and improve patient care. The CTSI will foster clinical and translational research, promote access to clinical trials, and develop novel methodologies.
The UCSF Institute will support innovative approaches in translational and clinical science across four schools, with a focus on accelerating the pace of scientific discovery into patient care. The institute's goal is to find more efficient ways to move basic research findings into the clinic.
Rockefeller University has been awarded a Clinical and Translational Science Award (CTSA) of over $45 million to enhance its infrastructure for translating scientific discoveries into improved health. The award will support translational researchers and train physician-scientists in clinical research.
Dr. Kodadek's research aims to develop substances that can diagnose and block specific immune responses without suppressing the entire immune system, potentially treating autoimmune diseases and cancer. He will receive $500,000 per year for five years to pursue this innovative approach.
Advances in biology are hindered by obstacles such as dwindling National Institutes of Health budgets and overly burdensome regulatory requirements. The Association of American Medical Colleges has outlined key recommendations to promote translational research, including increased investment in medical schools and teaching hospitals.
Two Yale Biomedical Engineers, Erin Lavik and Tarek Fahmy, have received Early Career Translational Research Awards for their innovative projects on glaucoma treatment and autoimmune disease diagnosis. The awards support their research collaborations with clinical investigators and provide two years of funding.
The NIH Clinical and Translational Science Awards (CTSAs) program aims to energize clinical and translational science at academic health centers nationwide. The program will foster collaborative approaches, encourage creative research methods, and lead to better patient outcomes through new prevention strategies and treatments.
Tony Hunter and Raymond N. DuBois have been awarded prestigious Landon-AACR Prizes for their significant contributions to understanding, treatment, and prevention of cancer. Their work has led to the development of anti-cancer drugs and potential mechanisms to inhibit enzyme activity.